UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016491
Receipt number R000019151
Scientific Title Pilot study about the imaging method of 18F-FLT in primary brain tumor
Date of disclosure of the study information 2015/02/09
Last modified on 2016/02/09 09:35:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pilot study about the imaging method of 18F-FLT in primary brain tumor

Acronym

BRAIN-FLT

Scientific Title

Pilot study about the imaging method of 18F-FLT in primary brain tumor

Scientific Title:Acronym

BRAIN-FLT

Region

Japan


Condition

Condition

Primary brain tumor

Classification by specialty

Radiology Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Basic data acquisition of PET image of 18F-FLT in primary brain tumor

Basic objectives2

Others

Basic objectives -Others

Data acquisition

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Integrated ratio of the lesion and the normal portion

Key secondary outcomes

Standard uptake value(SUV) of the striatum


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

Intravenous injection of 18F-FLT
PET imaging

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Subjects who were clinically diagnosed with primary glioma derived brain parenchyma
Over 30 years old
Subjects who the informed consent was obtained
Subjects Who is a health problem to participate in clinical research

Key exclusion criteria

Subjects who consciousness is not clear
Subjects with cerebrovascular disorder
Subjects with cardiac dysfunction
Subjects with high degree of arrhythmia
Subjects with liver and kidney failure
Subjects with serious lung disease, bronchial asthma and endocrine disease
Subjects who can not lay in the supine position during about 30 minutes for the pain
Subjects who is extreme claustrophobia
Pregnants or Subjects who have a possibility of pregnancy


Subjects who have the history of drug allergy
Subjects who are dehydration and malnutrition state
Subjects who are drug dependence, alcohol dependence
Subjects who reserchers judged as inappropriate

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michio Senda

Organization

Institute of Biomedical Research and Innovation

Division name

Division of Molecular Imaging

Zip code


Address

2-2, Minatojima-Minamimachi, Chuo-ku, Kobe

TEL

078-304-5212

Email

senda@fbri.org


Public contact

Name of contact person

1st name
Middle name
Last name Akihito Ohnishi

Organization

Institute of Biomedical Research and Innovation

Division name

Division of Molecular Imaging

Zip code


Address

2-2, Minatojima-Minamimachi, Chuo-ku, Kobe

TEL

078-304-5212

Homepage URL


Email

ohnishi@fbri.org


Sponsor or person

Institute

Institute of Biomedical Research and Innovation

Institute

Department

Personal name



Funding Source

Organization

Foundation of Biomedical Research and Innovation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

先端医療センター(兵庫県)


Other administrative information

Date of disclosure of the study information

2015 Year 02 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 10 Month 15 Day

Date of IRB


Anticipated trial start date

2014 Year 12 Month 01 Day

Last follow-up date

2015 Year 03 Month 31 Day

Date of closure to data entry

2015 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 02 Month 09 Day

Last modified on

2016 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019151


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name